NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
NBY on NYSE
Shares outstanding
125,955,831
Price per share
$6.20
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
226,659
Total reported value
$289,925
% of total 13F portfolios
0%
Share change
+8,137
Value change
+$135,650
Number of holders
13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
R01 Fund LP 45% +181% $74,228,505 +$72,707,353 56,806,080 +4780% R01 Fund LP 16 Oct 2025
Framework Ventures IV L.P. 45% +181% $74,228,505 +$72,707,353 56,806,080 +4780% Framework Ventures IV L.P. 16 Oct 2025
Lazar David E. 20% 0% $2,002,723 +$402,699 1,502,080 +25% David E. Lazar 16 Oct 2025
POPLAR POINT CAPITAL MANAGEMENT LLC 18% 0% $1,360,366 1,020,300 0% Poplar Point Capital Management LLC 15 Oct 2025

As of 30 Sep 2025, 13 institutional investors reported holding 226,659 shares of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY). This represents 0.18% of the company’s total 125,955,831 outstanding shares.

Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 226,659 $289,925 +$135,650 $1.28 13
2025 Q2 218,522 $126,743 -$84,498 $0.58 12
2025 Q1 362,238 $211,908 +$113,243 $0.58 15
2024 Q4 167,029 $100,725 +$22,013 $0.60 14
2024 Q3 125,970 $87,462 +$79,538 $0.69 12
2024 Q2 11,501 $25,420 +$25,420 $2.24 7